ducovest

IBDS:NYE-iShares iBonds Dec 2027 Term Corporate ETF (USD)

ETF | Target Maturity |

Last Closing

USD 24.35

Change

-0.02 (-0.08)%

Market Cap

USD 2.53B

Volume

0.35M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The fund will invest at least 80% of its assets in the component securities of the underlying index, and it will invest at least 90% of its assets in fixed income securities of the types included in the underlying index. The index is composed of U.S. dollar-denominated, investment-grade corporate bonds maturing in 2027.

Currency: USD

Country : USA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-18 )

Largest Industry Peers for Target Maturity

Symbol Name Price(Change) Market Cap
IBDR iShares iBonds Dec 2026 Term C..

N/A

 USD 2.86B
IBDQ iShares iBonds Dec 2025 Term C..

+0.01 (+0.04%)

 USD 2.76B
IBDT iShares iBonds Dec 2028 Term C..

-0.01 (-0.04%)

 USD 2.20B
IBDP iShares iBonds Dec 2024 Term C..

N/A

 N/A

ETFs Containing IBDS

N/A

Market Performance

  Market Performance vs. Industry/Classification (Target Maturity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.76% 100% F 31% F
Dividend Return 2.53% 20% F 51% F
Total Return 4.28% 80% B- 31% F
Trailing 12 Months  
Capital Gain 4.96% 80% B- 32% F
Dividend Return 3.61% 60% D- 52% F
Total Return 8.57% 80% B- 32% F
Trailing 5 Years  
Capital Gain -5.77% 40% F 38% F
Dividend Return 11.53% 80% B- 42% F
Total Return 5.77% 20% F 33% F
Average Annual (5 Year Horizon)  
Capital Gain -2.27% 40% F 26% F
Dividend Return 0.16% 60% D- 26% F
Total Return 2.43% 80% B- 51% F
Risk Return Profile  
Volatility (Standard Deviation) 6.15% 80% B- 88% B+
Risk Adjusted Return 2.56% 60% D- 26% F
Market Capitalization 2.53B 50% F 69% C-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.